AAAAAA
Results:
1-10
|
Results: 10
Authors:
Hartmann, JT
Fossa, SD
Nichols, CR
Droz, JP
Horwich, A
Gerl, A
Beyer, J
Pont, J
Fizazi, K
Hecker, H
Kanz, L
Einhorn, L
Bokemeyer, C
Citation: Jt. Hartmann et al., Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors, J NAT CANC, 93(22), 2001, pp. 1733-1738
Authors:
Hartmann, JT
Einhorn, L
Nichols, CR
Droz, JP
Horwich, A
Gerl, A
Fossa, SD
Beyer, J
Pont, J
Schmoll, HJ
Kanz, L
Bokemeyer, C
Citation: Jt. Hartmann et al., Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: Results of an international multicenter analysis, J CL ONCOL, 19(6), 2001, pp. 1641-1648
Authors:
De Santis, M
Bokemeyer, C
Becherer, A
Stoiber, F
Oechsle, K
Kletter, K
Dohmen, BM
Dittrich, C
Pont, J
Citation: M. De Santis et al., Predictive impact of 2-(18)fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma, J CL ONCOL, 19(17), 2001, pp. 3740-3744
Authors:
Fizazi, K
Tjulandin, S
Salvioni, R
Germa-Lluch, JR
Bouzy, J
Ragan, D
Bokemeyer, C
Gerl, A
Flechon, A
de Bono, JS
Stenning, S
Horwich, A
Pont, J
Albers, P
De Giorgi, U
Bower, M
Bulanov, A
Pizzocaro, G
Aparicio, J
Nichols, CR
Theodore, C
Hartmann, JT
Schmoll, HJ
Kaye, SB
Culine, S
Droz, JP
Mahe, C
Citation: K. Fizazi et al., Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: Prognostic factors and role of postsurgery chemotherapy-results from an international study group, J CL ONCOL, 19(10), 2001, pp. 2647-2657
Authors:
Bokemeyer, C
Droz, JP
Horwich, A
Gerl, A
Fossa, SD
Beyer, J
Pont, J
Schmoll, HJ
Kanz, L
Einhorn, L
Nichols, CR
Hartmann, JT
Citation: C. Bokemeyer et al., Extragonadal seminoma - An international multicenter analysis of prognostic factors and long term treatment outcome, CANCER, 91(7), 2001, pp. 1394-1401
Authors:
Hartmann, JT
Nichols, CR
Droz, JP
Horwich, A
Gerl, A
Fossa, SD
Beyer, J
Pont, J
Fizazi, K
Einhorn, L
Kanz, L
Bokemeyer, C
Citation: Jt. Hartmann et al., Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors, J NAT CANC, 92(1), 2000, pp. 54-61
Authors:
Hartmann, JT
Nichols, CR
Droz, JP
Horwich, A
Gerl, A
Fossa, SD
Beyer, J
Pont, J
Einhorn, L
Kanz, L
Bokemeyer, C
Citation: Jt. Hartmann et al., The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors, CANCER, 88(11), 2000, pp. 2629-2635
Authors:
DeSantis, M
Albrecht, W
Holtl, W
Pont, J
Citation: M. Desantis et al., Impact of cytotoxic treatment on long-term fertility in patients with germ-cell cancer, INT J CANC, 83(6), 1999, pp. 864-865
Authors:
Fossa, SD
Bokemeyer, C
Gerl, A
Culine, S
Jones, WG
Mead, GM
Germa-Luch, JR
Pont, J
Schmoll, HJ
Tjulandin, S
Citation: Sd. Fossa et al., Treatment outcome of patients with brain metastases from malignant germ cell tumors, CANCER, 85(4), 1999, pp. 988-997
Authors:
Pirker, RA
Pont, J
Pohnl, R
Schutz, W
Griesmacher, A
Muller, MM
Citation: Ra. Pirker et al., Usefulness of chromogranin A as a marker for detection of relapses of carcinoid tumours, CLIN CH L M, 36(11), 1998, pp. 837-840
Risultati:
1-10
|